Latest News

Todos Medical Announces Completion of Enrollment for COVID-19 Oral Antiviral 3CLPro (Mpro) Inhibitor Tollovir Phase 2 Clinical Trial Interim Analysis in Severe and Critical Hospitalized Patients

 Enrollment now paused in the randomized, double blind, placebo controlled clinical trial in severe and critical hospitalized COVID-19 patients to complete interim analysis Data from ...

Friendable CEO Interviewed by The Hype Magazine to Introduce Fan Pass Livestream Platform to Hype’s Audience and the Indie Music Artist Community

Friendable Intends to Use this Initial Introduction to Hype’s Audience (Approximately 300,000 Readers and More Than 1 Million Monthly Website Impressions) for More Targeted Promotions ...

Todos Medical Announces Tollovid Products Exclusive License & Distribution Agreement with T-Cell Protect Hellas S.A. Covering 30 Countries in Europe

The Agreement Calls for a Minimum of 500,000 Bottles in Sales Over 18 Months T-Cell Protect to Invest 1 Million Euros in Todos to Support ...

B2Digital’s B2 Fighting Series Heads to Elizabethtown for a Stacked Card at B2FS 140 After Massive Debut Success in Sioux City

Tampa, FL – (NewMediaWire) – November 18, 2021 – B2Digital Incorporated (the “Company” or “B2Digital”) (OTCMKTS:BTDG), the premier development league for mixed martial arts (“MMA”), ...